Mental Disorders
Conditions
Keywords
Shared Decision Making, Case Management, Decision Aid
Brief summary
The primary goal of the proposed study is to investigate the implementation and effectiveness of the mPOWR (Moving Patient-centered Outcomes through Wellness and Recovery) in diverse urban and rural community mental health settings. The study compares patient participation and outcomes using the mPOWR system to a usual care control condition. Four community mental health agencies participate in the research: two in San Francisco (urban) and two in N.M. (rural). One site in each setting serves as the mPOWR implementation site and the other serves as the control site. Service sites were randomly assigned to intervention or usual care conditions. A quasi experimental design was used; only eligible participants were enrolled in the study (e.g., exclusion criteria of moderate to severe cognitive impairment, patient services structured for provision of mPOWR implementation, etc.). The study design will employ repeated quantitative measures to assess change in outcomes within and across conditions over time. Qualitative methods in the form of focus group interviews will also be used to round out the information obtained about patient and provider expectations and experiences. Primary outcomes of interest include: Short Form Health Survey-12 (SF-12; physical and mental health aspects of health and well-being); Outcome Rating Scale (ORS; general well-being, personal well-being, close relationships, and work/school/friend relationships); Shared Decision Making Questionnaire (congruence of patient's and provider's participation in therapeutic decision making and patient's understanding of treatment and treatment options); Working Alliance Inventory (perception of therapeutic alliance); and Satisfaction Questionnaire (communication patterns between physicians and their patients).
Detailed description
Research on the impact of decision-support tools for providers and patients has not included frontline care managers within community mental health settings. In particular, the care management field lacks effective models for integrating results-based and patient-centered care into routine practice with diverse adults with complex mental health and social service needs. For over five years, Family Service Agency of San Francisco (FSA) developed and piloted a mental health decision-support tool entitled the Assessment Diagnostic Evaluation and Planning Tool (ADEPT) for use by patients and front-line providers. The ADEPT was developed by a team of researchers, frontline providers, and FSA patients to collect data and track patient progress over time. Yet, its strong focus on diagnostic screening and excessive length limited its relevance to patients in guiding service decisions. Over the past two years, a team of FSA patients and care managers revised the tool, eliminating its diagnostic component and retaining two measures of quality of life and community living skills that were reviewed and/or adapted by patients to reflect meaningful outcomes in the delivery of services. Decision aids and a communications toolkit were also developed to support the use of shared-decision making (SDM) processes in the provision of services. Together, these instruments and tools make up the Moving Patient Outcomes toward Wellness and Recovery (mPOWR) system. mPOWR ensures that the patient-provider relationship remains focused on patient identified outcomes and use of SDM throughout care. The primary goal of the study is to investigate the implementation and effectiveness of the mPOWR in diverse urban and rural community mental health settings. FSA has partnered with senior faculty from the University of New Mexico to serve as independent researchers for this study. The study involves four community mental health agencies: two in San Francisco (urban) and two in N.M. (rural). One (randomly chosen) site in each setting serves as the mPOWR implementation site and the other serves as the control site. The study population initially enrolled included 240 (60/site X 4 sites) diverse adults with chronic mental health conditions. The specific aims for this study are: (1) To improve patient and provider participation in shared-decision making and engagement in mental health treatment, to improve \[patient\] personal Quality of Life, and to improve \[patient\] access to community/social services; (2) To increase patient understanding of their treatment and of treatment options; to increase their personal treatment progress; (3) To increase patient functionality and sense of perceived support for their therapeutic outcomes. Primary outcomes of interest include: Short Form Health Survey-12 (SF-12; physical and mental health aspects of health and well-being); Outcome Rating Scale (ORS; general well-being, personal well-being, close relationships, and work/school/friend relationships); Shared Decision Making Questionnaire (congruence of patient's and provider's participation in therapeutic decision making and patient's understanding of treatment and treatment options); Working Alliance Inventory (perception of therapeutic alliance); and Satisfaction Questionnaire (communication patterns between physicians and their patients). Qualitative methods in the form of focus group interviews will also be used to round out the information obtained about patient and provider expectations and experiences. Data will be collected in a time series design.
Interventions
An mPOWR intervention and toolkit that consists of strategies, prompts, and decision aids designed to foster patient involvement in treatment. The mPOWR intervention includes a questionnaire that assesses quality of life and consumer functioning for use in the development of consumer-centered goals and outcomes within the mPOWR intervention.
Sponsors
Study design
Eligibility
Inclusion criteria
* Men and women over the age of 18 who are receiving mental health services.
Exclusion criteria
Temporary Exclusion: * Disruptive, aggressive, or severely disorganized behaviors; * Visibly intoxicated or under the influence of illicit drugs. General Exclusion: * Moderate to severe cognitive impairment; * Developmental disability that precludes comprehension; * Language issues: Intervention is only offered in English and Chinese; * Patient services structured for provision of mPOWR implementation (e.g., not in and out of inpatient or crisis stabilization services).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | Change in scores on the SF-12 from Baseline to 24 month follow-up | The physical health subscale (PCS-12; Physical Component Summary) of the SF-12 (Health Survey Short Form-12) was utilized in the current study to assess physical aspects of health and well-being48. The measure includes twelve questions asking about overall health, limitations from health conditions, physical health, emotional well-being and daily activities, and feelings over the past four weeks, utilizing variable Likert scale response choice options. The aggregate PCS subscale score of the SF-12 is calculated utilizing norm-based scoring with a weighted sum (Ware, Kosinski, & Keller, 1995). PCS scores in the present study ranged from 13.2 to 65.6, with higher values indicating better physical health. |
| Short Form Health Survey-12 (SF-12) Mental Symptoms | Change in scores on the SF-12 from Baseline to 24 month follow-up Description: The Health Survey Short Form-12 (SF-12) includes 12 items that assess for physical and mental aspects of health and well-being. | The mental health subscale (MCS-12; Mental Component Summary) of the SF-12 (Health Survey Short Form-12) was utilized in the current study to assess mental aspects of health and well-being48. The measure includes twelve questions asking about overall health, limitations from health conditions, physical health, emotional well-being and daily activities, and feelings over the past four weeks, utilizing variable Likert scale response choice options. The physical health subscale of the SF-12 was utilized as a key client functioning outcome in the current study. The aggregate MCS subscale score of the SF-12 is calculated utilizing norm-based scoring with a weighted sum (Ware, Kosinski, & Keller, 1995). MCS scores in the present study ranged from 9.6 to 72.0, with higher values indicating better physical health. |
| Outcome Rating Scale (ORS) | Change in scores on the Outcome Rating Scale from Baseline to 24 month follow-up | The Outcome Rating Scale (ORS) was utilized as a repeated measure of general therapy outcomes and quality of life changes during the course of therapy. The Outcome Rating Scale includes a visual analog scale (a horizontal line on which the participants marks how well they are doing within the last week from low to high) that records four questions about general well-being, personal well-being, close relationships, and work/school/friend relationships. Physical marks for each of four domains on the visual analog scale are measured by research team members with a ruler and converted to a score from 1 to 100. The four items are then averaged for an overall therapy outcome score. The total averaged ORS score ranges from 1 to 100, with higher scores indicating a better outcome. Analyses will examine treatment progress via change in ORS scores from pre- to post-intervention. |
| Shared Decision Making Questionnaire | Change in scores on the Shared Decision Making Questionnaire from Baseline to 24 month follow-up | A 6-item modified version of the Shared Decision Making Questionnaire (SDM-Q-9) 46 was utilized to assess client reports about the degree to which their provider involved them in understanding and making a treatment decision. Examples items included My provider discussed the advantages and disadvantages of options and strategies or My provider helped me understand all the information measured on a 6-point scale (completely disagree, strongly disagree, somewhat disagree, somewhat agree, strongly agree, and completely agree). The total average score ranges from 1 to 6 with higher scores indicating a better outcome of greater shared decision making. Analyses will examine change in Shared Decision Making Questionnaire scores from pre- to post-intervention. |
| Working Alliance Inventory | Change in scores on the Working Alliance Inventory from Baseline to 24 month follow-up | The Working Alliance Inventory measures the perception of therapeutic alliance in a clinical dyad during the process of developing a relationship required for effective psychotherapy. The current study utilized the client version of the Working Alliance Inventory included 7 items measured on a 7-point scale (never, rarely, occasionally, sometimes, often, very often, always). Example items included I am confident in my provider's ability to help me and My provider and I trust one another. The Working Alliance Inventory total average score ranges from 1 to 7, with high scores indicating a more positive outcome. Analyses will examine change in patient-reported Working Alliance Inventory scores from pre- to post-intervention. |
| Communication Satisfaction Questionnaire | Change in scores on the Communication Satisfaction Questionnaire from Baseline to 24 month follow-up | Communication satisfaction was measured utilizing a modified version of a 19-item measure of communication patterns between physicians and their clients (Campbell et al., 2007). Thirteen items focusing on the client's satisfaction with communication with their provider and their engagement in treatment were measured on a 7-point scale (strongly agree, agree, agree somewhat, undecided, disagree somewhat, disagree, strongly disagree). Example items included My provider checks to be sure that I understand everything or My provider involves me in decisions as much as I want. Total average scores range from 1 to 7 with higher scores indicating better communication satisfaction. Analyses will examine change in Satisfaction Questionnaire scores from pre- to post-intervention. |
Participant flow
Recruitment details
The research team distributed recruitment letters (in English and Chinese) via mail and in person in all four research sites. With assistance from case managers, research assistants introduced themselves to patients and invited participation. Recruitment occurred from October 2013 to June 2014.
Pre-assignment details
Enrollment was not directly related to the assignment of intervention, which was randomized at the site level. The screening predetermined criteria (exclusion of cognitive impairment). The number of individuals found eligible to participate was 266, and the research team subsequently randomly selected 240 participants.
Participants by arm
| Arm | Count |
|---|---|
| Intervention Site - Urban Setting The clinical case mangers at this site were trained to implement the intervention. This site is based in inner city San Francisco, CA. (Geriatric Services West) | 60 |
| Control Site - Urban Setting Treatment as usual. This site is based in inner city San Francisco, CA. (Gough Street Clinic) | 60 |
| Intervention Site - Rural Setting The clinical case mangers at this site were trained to implement the intervention. This site is based in rural New Mexico. (Tri-County Community Services in Taos, NM) | 60 |
| Control Site - Rural Setting Treatment as usual. This site is based in rural New Mexico. (Mental Health Resources in Clovis, NM) | 60 |
| Total | 240 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 |
|---|---|---|---|---|---|
| Overall Study | Cognitive Impairment | 5 | 0 | 1 | 0 |
| Overall Study | Death | 3 | 5 | 1 | 1 |
| Overall Study | Discharged from Study Site | 10 | 9 | 25 | 11 |
| Overall Study | Lost to Follow-up | 6 | 7 | 0 | 3 |
| Overall Study | Physician Decision | 4 | 0 | 0 | 0 |
| Overall Study | Withdrawal by Subject | 2 | 0 | 0 | 0 |
Baseline characteristics
| Characteristic | Intervention Site - Urban Setting | Control Site - Urban Setting | Intervention Site - Rural Setting | Control Site - Rural Setting | Total |
|---|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 47 Participants | 41 Participants | 6 Participants | 8 Participants | 102 Participants |
| Age, Categorical Between 18 and 65 years | 13 Participants | 19 Participants | 54 Participants | 50 Participants | 136 Participants |
| Race/Ethnicity, Customized Race/Ethnicity American Indian or Alaskan Native | 0 Participants | 1 Participants | 1 Participants | 0 Participants | 2 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Asian or Pacific Islander | 16 Participants | 5 Participants | 0 Participants | 0 Participants | 21 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Black, not Hispanic | 6 Participants | 10 Participants | 0 Participants | 0 Participants | 16 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Hispanic | 5 Participants | 4 Participants | 32 Participants | 20 Participants | 61 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Mixed | 0 Participants | 1 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Other | 3 Participants | 1 Participants | 1 Participants | 0 Participants | 5 Participants |
| Race/Ethnicity, Customized Race/Ethnicity Unknown | 0 Participants | 0 Participants | 1 Participants | 3 Participants | 4 Participants |
| Race/Ethnicity, Customized Race/Ethnicity White, not Hispanic | 30 Participants | 38 Participants | 25 Participants | 37 Participants | 130 Participants |
| Region of Enrollment United States | 60 Participants | 60 Participants | 60 Participants | 60 Participants | 240 Participants |
| Sex/Gender, Customized Female | 34 Participants | 30 Participants | 28 Participants | 35 Participants | 127 Participants |
| Sex/Gender, Customized Male | 26 Participants | 29 Participants | 32 Participants | 25 Participants | 112 Participants |
| Sex/Gender, Customized Other | 0 Participants | 1 Participants | 0 Participants | 0 Participants | 1 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk |
|---|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 60 | 0 / 60 | 0 / 60 | 0 / 60 |
| serious Total, serious adverse events | 3 / 60 | 5 / 60 | 1 / 60 | 1 / 60 |
Outcome results
Communication Satisfaction Questionnaire
Communication satisfaction was measured utilizing a modified version of a 19-item measure of communication patterns between physicians and their clients (Campbell et al., 2007). Thirteen items focusing on the client's satisfaction with communication with their provider and their engagement in treatment were measured on a 7-point scale (strongly agree, agree, agree somewhat, undecided, disagree somewhat, disagree, strongly disagree). Example items included My provider checks to be sure that I understand everything or My provider involves me in decisions as much as I want. Total average scores range from 1 to 7 with higher scores indicating better communication satisfaction. Analyses will examine change in Satisfaction Questionnaire scores from pre- to post-intervention.
Time frame: Change in scores on the Communication Satisfaction Questionnaire from Baseline to 24 month follow-up
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Communication Satisfaction Questionnaire | Baseline | 4.283 units on a scale | Standard Deviation 0.53 |
| Intervention Site - Urban Setting | Communication Satisfaction Questionnaire | 24 Month Follow-up | 3.947 units on a scale | Standard Deviation 0.478 |
| Control Site - Urban Setting | Communication Satisfaction Questionnaire | 24 Month Follow-up | 4.093 units on a scale | Standard Deviation 0.529 |
| Control Site - Urban Setting | Communication Satisfaction Questionnaire | Baseline | 4.024 units on a scale | Standard Deviation 0.706 |
| Intervention Site - Rural Setting | Communication Satisfaction Questionnaire | Baseline | 4.363 units on a scale | Standard Deviation 0.564 |
| Intervention Site - Rural Setting | Communication Satisfaction Questionnaire | 24 Month Follow-up | 4.135 units on a scale | Standard Deviation 0.769 |
| Control Site - Rural Setting | Communication Satisfaction Questionnaire | Baseline | 4.473 units on a scale | Standard Deviation 0.578 |
| Control Site - Rural Setting | Communication Satisfaction Questionnaire | 24 Month Follow-up | 4.065 units on a scale | Standard Deviation 0.69 |
Outcome Rating Scale (ORS)
The Outcome Rating Scale (ORS) was utilized as a repeated measure of general therapy outcomes and quality of life changes during the course of therapy. The Outcome Rating Scale includes a visual analog scale (a horizontal line on which the participants marks how well they are doing within the last week from low to high) that records four questions about general well-being, personal well-being, close relationships, and work/school/friend relationships. Physical marks for each of four domains on the visual analog scale are measured by research team members with a ruler and converted to a score from 1 to 100. The four items are then averaged for an overall therapy outcome score. The total averaged ORS score ranges from 1 to 100, with higher scores indicating a better outcome. Analyses will examine treatment progress via change in ORS scores from pre- to post-intervention.
Time frame: Change in scores on the Outcome Rating Scale from Baseline to 24 month follow-up
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Outcome Rating Scale (ORS) | Baseline | 58.085 units on a scale | Standard Deviation 24.192 |
| Intervention Site - Urban Setting | Outcome Rating Scale (ORS) | 24 Month Follow-up | 54.083 units on a scale | Standard Deviation 29.634 |
| Control Site - Urban Setting | Outcome Rating Scale (ORS) | 24 Month Follow-up | 56.987 units on a scale | Standard Deviation 28.737 |
| Control Site - Urban Setting | Outcome Rating Scale (ORS) | Baseline | 49.003 units on a scale | Standard Deviation 29.995 |
| Intervention Site - Rural Setting | Outcome Rating Scale (ORS) | Baseline | 57.522 units on a scale | Standard Deviation 23.978 |
| Intervention Site - Rural Setting | Outcome Rating Scale (ORS) | 24 Month Follow-up | 47.083 units on a scale | Standard Deviation 29.46 |
| Control Site - Rural Setting | Outcome Rating Scale (ORS) | Baseline | 59.583 units on a scale | Standard Deviation 24.171 |
| Control Site - Rural Setting | Outcome Rating Scale (ORS) | 24 Month Follow-up | 61.433 units on a scale | Standard Deviation 21.688 |
Shared Decision Making Questionnaire
A 6-item modified version of the Shared Decision Making Questionnaire (SDM-Q-9) 46 was utilized to assess client reports about the degree to which their provider involved them in understanding and making a treatment decision. Examples items included My provider discussed the advantages and disadvantages of options and strategies or My provider helped me understand all the information measured on a 6-point scale (completely disagree, strongly disagree, somewhat disagree, somewhat agree, strongly agree, and completely agree). The total average score ranges from 1 to 6 with higher scores indicating a better outcome of greater shared decision making. Analyses will examine change in Shared Decision Making Questionnaire scores from pre- to post-intervention.
Time frame: Change in scores on the Shared Decision Making Questionnaire from Baseline to 24 month follow-up
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Shared Decision Making Questionnaire | Baseline | 4.698 units on a scale | Standard Deviation 1.289 |
| Intervention Site - Urban Setting | Shared Decision Making Questionnaire | 24 Month Follow-up | 4.512 units on a scale | Standard Deviation 0.872 |
| Control Site - Urban Setting | Shared Decision Making Questionnaire | 24 Month Follow-up | 4.363 units on a scale | Standard Deviation 0.999 |
| Control Site - Urban Setting | Shared Decision Making Questionnaire | Baseline | 4.005 units on a scale | Standard Deviation 1.293 |
| Intervention Site - Rural Setting | Shared Decision Making Questionnaire | Baseline | 4.995 units on a scale | Standard Deviation 0.907 |
| Intervention Site - Rural Setting | Shared Decision Making Questionnaire | 24 Month Follow-up | 5.270 units on a scale | Standard Deviation 0.827 |
| Control Site - Rural Setting | Shared Decision Making Questionnaire | Baseline | 5.220 units on a scale | Standard Deviation 0.673 |
| Control Site - Rural Setting | Shared Decision Making Questionnaire | 24 Month Follow-up | 5.239 units on a scale | Standard Deviation 0.665 |
Short Form Health Survey-12 (SF-12) Mental Symptoms
The mental health subscale (MCS-12; Mental Component Summary) of the SF-12 (Health Survey Short Form-12) was utilized in the current study to assess mental aspects of health and well-being48. The measure includes twelve questions asking about overall health, limitations from health conditions, physical health, emotional well-being and daily activities, and feelings over the past four weeks, utilizing variable Likert scale response choice options. The physical health subscale of the SF-12 was utilized as a key client functioning outcome in the current study. The aggregate MCS subscale score of the SF-12 is calculated utilizing norm-based scoring with a weighted sum (Ware, Kosinski, & Keller, 1995). MCS scores in the present study ranged from 9.6 to 72.0, with higher values indicating better physical health.
Time frame: Change in scores on the SF-12 from Baseline to 24 month follow-up Description: The Health Survey Short Form-12 (SF-12) includes 12 items that assess for physical and mental aspects of health and well-being.
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | Baseline | 43.828 units on a scale | Standard Deviation 14.15 |
| Intervention Site - Urban Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | 24 Month Follow-up | 39.931 units on a scale | Standard Deviation 12.795 |
| Control Site - Urban Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | 24 Month Follow-up | 39.570 units on a scale | Standard Deviation 13.714 |
| Control Site - Urban Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | Baseline | 38.647 units on a scale | Standard Deviation 13.623 |
| Intervention Site - Rural Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | Baseline | 34.153 units on a scale | Standard Deviation 12.288 |
| Intervention Site - Rural Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | 24 Month Follow-up | 35.850 units on a scale | Standard Deviation 11.915 |
| Control Site - Rural Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | Baseline | 39.970 units on a scale | Standard Deviation 13.033 |
| Control Site - Rural Setting | Short Form Health Survey-12 (SF-12) Mental Symptoms | 24 Month Follow-up | 37.768 units on a scale | Standard Deviation 11.092 |
Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale
The physical health subscale (PCS-12; Physical Component Summary) of the SF-12 (Health Survey Short Form-12) was utilized in the current study to assess physical aspects of health and well-being48. The measure includes twelve questions asking about overall health, limitations from health conditions, physical health, emotional well-being and daily activities, and feelings over the past four weeks, utilizing variable Likert scale response choice options. The aggregate PCS subscale score of the SF-12 is calculated utilizing norm-based scoring with a weighted sum (Ware, Kosinski, & Keller, 1995). PCS scores in the present study ranged from 13.2 to 65.6, with higher values indicating better physical health.
Time frame: Change in scores on the SF-12 from Baseline to 24 month follow-up
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | Baseline | 38.167 units on a scale | Standard Deviation 11.067 |
| Intervention Site - Urban Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | 24 Month Follow-up | 34.386 units on a scale | Standard Deviation 8.801 |
| Control Site - Urban Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | 24 Month Follow-up | 35.884 units on a scale | Standard Deviation 12.343 |
| Control Site - Urban Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | Baseline | 38.601 units on a scale | Standard Deviation 10.595 |
| Intervention Site - Rural Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | Baseline | 37.187 units on a scale | Standard Deviation 12.585 |
| Intervention Site - Rural Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | 24 Month Follow-up | 36.354 units on a scale | Standard Deviation 9.734 |
| Control Site - Rural Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | Baseline | 37.108 units on a scale | Standard Deviation 10.148 |
| Control Site - Rural Setting | Short Form Health Survey-12 (SF-12), Physical Symptoms Subscale | 24 Month Follow-up | 37.163 units on a scale | Standard Deviation 12.555 |
Working Alliance Inventory
The Working Alliance Inventory measures the perception of therapeutic alliance in a clinical dyad during the process of developing a relationship required for effective psychotherapy. The current study utilized the client version of the Working Alliance Inventory included 7 items measured on a 7-point scale (never, rarely, occasionally, sometimes, often, very often, always). Example items included I am confident in my provider's ability to help me and My provider and I trust one another. The Working Alliance Inventory total average score ranges from 1 to 7, with high scores indicating a more positive outcome. Analyses will examine change in patient-reported Working Alliance Inventory scores from pre- to post-intervention.
Time frame: Change in scores on the Working Alliance Inventory from Baseline to 24 month follow-up
Population: Several factors influenced variability in the number of participants analyzed across time points. First, patients may have responded to some items but opted out of others because of questionnaire length or comprehension considerations. Second, some patients were available at baseline but were unavailable at subsequent time points, or vice versa.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Intervention Site - Urban Setting | Working Alliance Inventory | Baseline | 5.896 units on a scale | Standard Deviation 1.065 |
| Intervention Site - Urban Setting | Working Alliance Inventory | 24 Month Follow-up | 5.842 units on a scale | Standard Deviation 0.941 |
| Control Site - Urban Setting | Working Alliance Inventory | 24 Month Follow-up | 5.810 units on a scale | Standard Deviation 1.344 |
| Control Site - Urban Setting | Working Alliance Inventory | Baseline | 5.494 units on a scale | Standard Deviation 1.086 |
| Intervention Site - Rural Setting | Working Alliance Inventory | 24 Month Follow-up | 5.723 units on a scale | Standard Deviation 1.182 |
| Intervention Site - Rural Setting | Working Alliance Inventory | Baseline | 6.203 units on a scale | Standard Deviation 0.751 |
| Control Site - Rural Setting | Working Alliance Inventory | 24 Month Follow-up | 5.751 units on a scale | Standard Deviation 1.042 |
| Control Site - Rural Setting | Working Alliance Inventory | Baseline | 6.058 units on a scale | Standard Deviation 1.045 |